It hasn't been approved by the FDA yet
Retatrutide is a triple agonist (GIP, GLP-1, and glucagon receptors) while Ozempic activates only GLP-1 receptors, resulting in significantly greater weight loss, 24.2% versus 14.9% at standard doses
[2] When considering supplements, it's important to view them as supporting a healthy diet rather than replacing nutrients
This article examines the current evidence, potential risks, and the importance of evidence-based treatment decisions in rheumatoid arthritis management
"So to double the dose of a drug acting on these pathways, we know for certain with similar drugs like steroids, that it can have drastic effects on the body." He said in the controlled environment of clinical trials, retatrutide was showing "some positive effects", but unapproved peptides bought online could contain incorrect dosing and contaminants